Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic

S Lin, LHS Lau, N Chanchlani, NA Kennedy, SC Ng - Gut, 2022 - gut.bmj.com
The COVID-19 pandemic has raised considerable concerns that patients with inflammatory
bowel disease (IBD), particularly those treated with immunosuppressive therapies, may …

COVID‐19 susceptibility and clinical outcomes in inflammatory bowel disease: An updated systematic review and meta‐analysis

MH Lee, HJ Li, P Wasuwanich, SE Kim… - Reviews in Medical …, 2023 - Wiley Online Library
The susceptibility, risk factors, and prognosis of COVID‐19 in patients with inflammatory
bowel disease (IBD) remain unknown. Thus, our study aims to assess the prevalence and …

Cytokine Storm-Induced Thyroid Dysfunction in COVID-19: Insights into Pathogenesis and Therapeutic Approaches

A Attiq, S Afzal, HA Wahab, W Ahmad… - Drug Design …, 2024 - Taylor & Francis
Angiotensin-converting enzyme 2 receptors (ACE2R) are requisite to enter the host cells for
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). ACE2R is constitutive and …

Inflammatory bowel disease and COVID-19 outcomes: a meta-analysis

M Abdulla, N Mohammed, J AlQamish, M Mosli - Scientific Reports, 2022 - nature.com
There is conflicting evidence concerning the effect of inflammatory bowel disease (IBD) on
COVID-19 incidence and outcome. Hence, we aimed to evaluate the published evidence …

Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysis

F Alrashed, R Battat, I Abdullah… - BMJ Open …, 2021 - bmjopengastro.bmj.com
Background During COVID-19 pandemic, the safety of medical therapies for inflammatory
bowel disease (IBD) in relation to COVID-19 has emerged as an area of concern. This study …

SARS-CoV-2 infection and outcomes in children with inflammatory bowel diseases: a systematic review

A Batsiou, P Mantzios, D Piovani, AG Tsantes… - Journal of Clinical …, 2022 - mdpi.com
The impact of COVID-19 on pediatric patients with inflammatory bowel disease (PIBD) is still
not clear and the knowledge acquired over the last 2 years is still evolving. This study aims …

COVID-19 and Gastrointestinal Tract: From Pathophysiology to Clinical Manifestations

F Vernia, H Ashktorab, N Cesaro, S Monaco, S Faenza… - Medicina, 2023 - mdpi.com
Background: Since its first report in Wuhan, China, in December 2019, COVID-19 has
become a pandemic, affecting millions of people worldwide. Although the virus primarily …

Impact of biologics and small molecules for inflammatory bowel disease on COVID‐19‐related hospitalization and mortality: A systematic review and meta‐analysis

F Alrashed, H Alasfour, M Shehab - JGH Open, 2022 - Wiley Online Library
Abstract Background and Aim The use of biologics and small molecules has been a concern
for patients with inflammatory bowel disease (IBD) during the COVID‐19 pandemic. We …

Healthy Habits, Physical Activity, Stress, and Food Consumption Trends in Chilean Adults with Irritable Bowel Syndrome during the COVID-19 Pandemic

C Mandiola-Palma, C Leiva, MJ Moya-Salazar… - International Journal of …, 2024 - mdpi.com
The COVID-19 pandemic has increased stress levels in the population due to radical
lifestyle changes caused by containment measures. Studies suggest that high levels of …

The association between ulcerative colitis and COVID-19 severity: a systematic review and meta-analysis systematic review

J Yang, J Ke, X Jiang, L Wang - International Journal of Colorectal …, 2023 - Springer
Purpose After the COVID-19 pandemic, many challenges arose regarding the impact of this
disease on people with ulcerative colitis. The aims of this study were to estimate the …